Thorax 2000;55:1046-1051 ( December )

Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy

R Schulz, D Schmidt, A Blum, X Lopes-Ribeiro, C Lücke, K Mayer, H Olschewski, W Seeger, F Grimminger

Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Justus-Liebig University, 35392 Gieen, Germany

Correspondence to: Dr R Schulz

Received 22 December 1999; Returned to authors 20 March 2000; Revised version received 24 May 2000; Accepted for publication 8 August 2000

BACKGROUNDReduced endothelium dependent vasodilation has been reported in patients with obstructive sleep apnoea (OSA) but direct measurements of the most potent naturally occurring vasodilator, nitric oxide (NO) or its derivatives (nitrate and nitrite, NO_x), have not yet been performed in these patients.
METHODSIn 21 patients with OSA of mean (SE) age 54 (2) years, body mass index (BMI) 30.9 (1.1) kg/m², and apnoea-hypopnoea index (AHI) 37 (4)/h, NO_x levels were measured in peripheral venous blood samples by chemiluminescence. Blood samples were obtained before and after two nights of continuous positive airway pressure (CPAP) and after 5.5 (1.5) months of follow up. Thirteen age matched, healthy volunteers and 18 patients without OSA but with a similar spectrum of comorbidity served as controls (control groups 1 and 2).
RESULTSBefore CPAP NO_x levels were 21.7 (1.5) µM in patients with OSA compared with 42.6 (2.2) µM and 36.7 (1.7) µM in control groups 1 and 2, respectively (p<0.01 for each comparison). NO_x concentrations increased to 32.1 (2.7) µM after two nights of CPAP and remained constant at 32.9 (2.3) µM at follow up (p<0.01 compared with levels before CPAP).
CONCLUSIONSPlasma NO_x levels are reduced in OSA and can be increased by short and long term CPAP therapy. Although the precise mechanism underlying this observation remains to be clarified, it may have important implications for the development of cardiovascular disease in patients with OSA and for the life saving effect of CPAP.


Keywords: obstructive sleep apnoea; nitric oxide; CPAP therapy

---

© 2000 by Thorax
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Alonso-Fernandez, A, Garcia-Rio, F, Arias, M A, Hernanz, A, de la Pena, M, Pierola, J, Barcelo, A, Lopez-Collazo, E, Agusti, A (2009). Effects of CPAP on oxidative stress and nitrate efficiency in sleep apnoea: a randomised trial. Thorax 64: 581-586 [Abstract] [Full Text]  
• Foster, G. E., Brugniaux, J. V., Pialoux, V., Duggan, C. T. C., Hanly, P. J., Ahmed, S. B., Poulin, M. J. (2009). Cardiovascular and cerebrovascular responses to acute hypoxia following exposure to intermittent hypoxia in healthy humans. J. Physiol. 587: 3287-3299 [Abstract] [Full Text]  
• Lavie, L., Lavie, P. (2009). Molecular mechanisms of cardiovascular disease in OSAHS: the oxidative stress link. Eur Respir J 33: 1467-1484 [Abstract] [Full Text]  
• Kuhlmann, U., Bormann, F. G., Becker, H. F. (2009). Obstructive sleep apnoea: clinical signs, diagnosis and treatment. Nephrol Dial Transplant 24: 8-14 [Full Text]  
• Lott, M. E. J., Hogeman, C., Herr, M., Bhagat, M., Kunselman, A., Sinoway, L. I. (2009). Vasoconstrictor responses in the upper and lower limbs to increases in transmural pressure. J. Appl. Physiol. 106: 302-310 [Abstract] [Full Text]  
• Levy, P., Pepin, J-L., Arnaud, C., Tamisier, R., Borel, J-C., Dematteis, M., Godin-Ribuot, D., Ribuot, C. (2008). Intermittent hypoxia and sleep-disordered breathing: current concepts and perspectives. Eur Respir J 32: 1082-1095 [Abstract] [Full Text]  
• Sorajja, D., Gami, A. S., Somers, V. K., Behrenbeck, T. R., Garcia-Touchard, A., Lopez-Jimenez, F. (2008). Independent Association Between Obstructive Sleep Apnea and Subclinical Coronary Artery Disease. Chest 133: 927-933 [Abstract] [Full Text]  
• Tasali, E., Ip, M. S. M. (2008). Obstructive Sleep Apnea and Metabolic Syndrome: Alterations in Glucose Metabolism and Inflammation. Proc Am Thorac Soc 5: 207-217 [Abstract] [Full Text]  
• Gozal, D., Kheirandish-Gozal, L. (2008). Cardiovascular Morbidity in Obstructive Sleep Apnea: Oxidative Stress, Inflammation, and Much More. Am. J. Respir. Crit. Care Med. 177: 369-375 [Abstract] [Full Text]  
• Buyse, B., Hedner, J., the participants of working group 2, (2007). Sleep apnoea, hypertension and vascular disease: where are we now?. ERR 16: 169-182 [Abstract] [Full Text]  
• McNicholas, W. T. (2007). Cardiovascular outcomes of CPAP therapy in obstructive sleep apnea syndrome. Am. J. Physiol. Regul. Integr. Comp. Physiol. 293: R1666-R1670 [Abstract] [Full Text]  
• Parati, G., Lombardi, C., Narkiewicz, K. (2007). Sleep apnea: epidemiology, pathophysiology, and relation to cardiovascular risk. Am. J. Physiol. Regul. Integr. Comp. Physiol. 293: R1671-R1683 [Abstract] [Full Text]  
• Foresi, A., Leone, C., Olivieri, D., Cremona, G. (2007). Alveolar-Derived Exhaled Nitric Oxide Is Reduced in Obstructive Sleep Apnea Syndrome. Chest 132: 860-867 [Abstract] [Full Text]  
• El Solh, A. A., Akinnusi, M. E., Baddoura, F. H., Mankowski, C. R. (2007). Endothelial Cell Apoptosis in Obstructive Sleep Apnea: A Link to Endothelial Dysfunction. Am. J. Respir. Crit. Care Med. 175: 1186-1191 [Abstract] [Full Text]  
• Foster, G. E., Hanly, P. J., Ostrowski, M., Poulin, M. J. (2007). Effects of Continuous Positive Airway Pressure on Cerebral Vascular Response to Hypoxia in Patients with Obstructive Sleep Apnea. Am. J. Respir. Crit. Care Med. 175: 720-725 [Abstract] [Full Text]  
• McNicholas, W. T., Bonsignore, M. R., the Management Committee of EU COST ACTION B26, (2007). Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J 29: 156-178 [Abstract] [Full Text]  
• Wolk, R., Somers, V. K. (2007). Sleep Apnoea & Hypertension: Physiological bases for a causal relation: Sleep and the metabolic syndrome. Exp Physiol 92: 67-78 [Abstract] [Full Text]  
• Foster, G. E., Poulin, M. J., Hanly, P. J. (2007). Sleep Apnoea & Hypertension: Physiological bases for a causal relation: Intermittent hypoxia and vascular function: implications for obstructive sleep apnoea. Exp Physiol 92: 51-65 [Abstract] [Full Text]  
• Simantirakis, E. N., Vardas, P. E. (2006). Cardiac pacing in sleep apnoea: diagnostic and therapeutic implications.. Europace 8: 984-987 [Abstract] [Full Text]  
• Lattimore, J L, Wilcox, I, Skilton, M, Langenfeld, M, Celermajer, D S (2006). Treatment of obstructive sleep apnoea leads to improved microvascular endothelial function in the systemic circulation. Thorax 61: 491-495 [Abstract] [Full Text]  
• El Solh, A. A., Saliba, R., Bosinski, T., Grant, B. J. B., Berbary, E., Miller, N. (2006). Allopurinol improves endothelial function in sleep apnoea: a randomised controlled study.. Eur Respir J 27: 997-1002 [Abstract] [Full Text]  
• Ferreira, S., Winck, J., Bettencourt, P., Rocha-Goncalves, F. (2006). Heart failure and sleep apnoea: To sleep perchance to dream. Eur J Heart Fail 8: 227-236 [Abstract] [Full Text]  
• Grebe, M., Eisele, H. J., Weissmann, N., Schaefer, C., Tillmanns, H., Seeger, W., Schulz, R. (2006). Antioxidant Vitamin C Improves Endothelial Function in Obstructive Sleep Apnea. Am. J. Respir. Crit. Care Med. 173: 897-901 [Abstract] [Full Text]  
• Shivalkar, B., Van De Heyning, C., Kerremans, M., Rinkevich, D., Verbraecken, J., De Backer, W., Vrints, C. (2006). Obstructive Sleep Apnea Syndrome: More Insights on Structural and Functional Cardiac Alterations, and the Effects of Treatment With Continuous Positive Airway Pressure. J Am Coll Cardiol 47: 1433-1439 [Abstract] [Full Text]  
• Simantirakis, E. N., Schiza, S. E., Chrysostomakis, S. I., Chlouverakis, G. I., Klapsinos, N. C., Siafakas, N. M., Vardas, P. E. (2005). Atrial Overdrive Pacing for the Obstructive Sleep Apnea-Hypopnea Syndrome. NEJM 353: 2568-2577 [Abstract] [Full Text]  
• Baguet, J.-P., Hammer, L., Levy, P., Pierre, H., Launois, S., Mallion, J.-M., Pepin, J.-L. (2005). The Severity of Oxygen Desaturation Is Predictive of Carotid Wall Thickening and Plaque Occurrence. Chest 128: 3407-3412 [Abstract] [Full Text]  
• Caples, S. M., Gami, A. S., Somers, V. K. (2005). Obstructive Sleep Apnea. Focus 3: 557-567 [Full Text]  
• Schulz, R. (2005). The vascular micromilieu in obstructive sleep apnoea. Eur Respir J 25: 780-782 [Full Text]  
• Caples, S. M., Gami, A. S., Somers, V. K. (2005). Obstructive Sleep Apnea. ANN INTERN MED 142: 187-197 [Full Text]  
• Schulz, R., Seeger, W., Fegbeutel, C., Husken, H., Bodeker, R. H., Tillmanns, H., Grebe, M. (2005). Changes in extracranial arteries in obstructive sleep apnoea. Eur Respir J 25: 69-74 [Abstract] [Full Text]  
• Svatikova, A., Wolk, R., Magera, M. J, Shamsuzzaman, A. S, Phillips, B. G, Somers, V. K (2004). Plasma homocysteine in obstructive sleep apnoea. Eur Heart J 25: 1325-1329 [Abstract] [Full Text]  
• Svatikova, A., Wolk, R., Wang, H. H., Otto, M. E., Bybee, K. A., Singh, R. J., Somers, V. K. (2004). Circulating free nitrotyrosine in obstructive sleep apnea. Am. J. Physiol. Regul. Integr. Comp. Physiol. 287: R284-R287 [Abstract] [Full Text]  
• Javaheri, S., Abraham, W. T., Brown, C., Nishiyama, H., Giesting, R., Wagoner, L. E. (2004). Prevalence of obstructive sleep apnoea and periodic limb movement in 45 subjects with heart transplantation. Eur Heart J 25: 260-266 [Abstract] [Full Text]  
• Phillips, S. A., Olson, E. B., Morgan, B. J., Lombard, J. H. (2004). Chronic intermittent hypoxia impairs endothelium-dependent dilation in rat cerebral and skeletal muscle resistance arteries. Am. J. Physiol. Heart Circ. Physiol. 286: H388-H393 [Abstract] [Full Text]  
• Shamsuzzaman, A. S. M., Gersh, B. J., Somers, V. K. (2003). Obstructive Sleep Apnea: Implications for Cardiac and Vascular Disease. JAMA 290: 1906-1914 [Abstract] [Full Text]  
• Schmidt, A., Geigenmueller, S., Voelker, W., Seiler, P., Buddecke, E. (2003). Exogenous nitric oxide causes overexpression of TGF-{beta}1 and overproduction of extracellular matrix in human coronary smooth muscle cells. Cardiovasc Res 58: 671-678 [Abstract] [Full Text]  
• Lattimore, J. o-D. L., Celermajer, D. S., Wilcox, I. (2003). Obstructive sleep apnea and cardiovascular disease. J Am Coll Cardiol 41: 1429-1437 [Abstract] [Full Text]  
• Hui, D. S.C., Choy, D. K.L., Wong, L. K.S., Ko, F. W.S., Li, T. S.T., Woo, J., Kay, R. (2002). Prevalence of Sleep-Disordered Breathing and Continuous Positive Airway Pressure Compliance* : Results in Chinese Patients With First-Ever Ischemic Stroke. Chest 122: 852-860 [Abstract] [Full Text]  
• Fung, J. W. H., Li, T. S. T., Choy, D. K. L., Yip, G. W. K., Ko, F. W. S., Sanderson, J. E., Hui, D. S. C. (2002). Severe Obstructive Sleep Apnea Is Associated With Left Ventricular Diastolic Dysfunction. Chest 121: 422-429 [Abstract] [Full Text]  
• SCHULZ, R., HUMMEL, C., HEINEMANN, S., SEEGER, W., GRIMMINGER, F. (2002). Serum Levels of Vascular Endothelial Growth Factor Are Elevated in Patients with Obstructive Sleep Apnea and Severe Nighttime Hypoxia. Am. J. Respir. Crit. Care Med. 165: 67-70 [Abstract] [Full Text]  
• Lavie, L., Perelman, A., Lavie, P. (2001). Plasma Homocysteine Levels in Obstructive Sleep Apnea : Association With Cardiovascular Morbidity. Chest 120: 900-908 [Abstract] [Full Text]